Leadership

Our proven executive team brings deep, diverse cell therapy experience and is committed to developing safe, effective, and accessible NK cell therapies to patients. Artiva's Board of Directors and Advisors bring years of expertise to help us realize the full potential of NK cell therapies.

Executives Directors Advisors

Fred Aslan, M.D.

President and Chief Executive Officer

View Bio »

Jennifer Bush

Chief Operating Officer

View Bio »

Thorsten Graef, M.D., Ph.D.

Chief Medical Officer

View Bio »

Christopher Horan

Chief Technical Operations Officer

View Bio »

Neha Krishnamohan

Chief Financial Officer and EVP, Corporate Development

View Bio »

Eugene Helsel

SVP, Regulatory Affairs

View Bio »

John Lim, Pharm.D.

SVP, Clinical Operations

View Bio »

Heather Raymon, Ph.D.

SVP, Research & Early Development

View Bio »

Nicholas Veomett, Ph.D.

VP, Corporate Development, AlloNK Program Lead

View Bio »